Search results
Can nasal Neosporin fight COVID? Surprising new research suggests it works
Salon via Yahoo News· 2 hours agoNot exactly, but it probably wouldn’t hurt either — as long as someone isn’t allergic to the cream,...
Shortness of breath, fatigue characterises Long COVID
Cosmos· 5 hours agoA study of Swedish Long COVID patients has revealed the symptoms most commonly associated with the...
Covid-19 Pandemic Led To Growing Acceptance Of Doctors Withholding Treatment
Forbes· 7 hours agoWhile most researchers, policymakers, lawyers, and journalists have always advocated that doctors are obligated to treat patients with infectious diseases, the Covid-19 pandemic ...
Long-COVID patients more likely to report psychiatric symptoms, cost barriers to therapy
Center for Infectious Disease Research and Policy· 18 hours agoA study in JAMA Network Open finds that while US adults with long COVID have a higher rate of...
NIH RECOVER Makes Long COVID Data Easier to Access - Deidentified Data from Thousands of Adults with...
Sierra Sun Times· 22 hours agoDeidentified data from thousands of adults with long COVID are now available to researchers. April...
Are Monoclonal Antibodies the Future of Long COVID Treatments?
Technology Networks· 4 days agoThe bulk of long COVID research carried out over the past four years has attempted to understand the...
3 Dividend Stocks to Buy and Hold for the Next Decade
Motley Fool via Yahoo Finance· 43 minutes agoCFO Dave Denton told analysts in January that growing the dividend is the company's first capital...
CompendiRx Unveils Innovative Approach to Long COVID: Empowering Patients Worldwide
Digital Journal· 23 hours agoWe invite patients, caregivers, healthcare professionals, and anyone touched by the shadow of long COVID to join us in this journey." CompendiRx confronts ...
Groundbreaking UTMB Health research study reveals surprising link between Long COVID, traumatic...
Community Impact· 6 days agoA new research study conducted by UTMB’s Dr. Randall Urban and Dr. Richard “Rick” Pyles has...
Gilead Gives Up Big Gains As Covid Drug Drives Its Beat — Again
Investor's Business Daily· 16 hours agoIn morning trades, Gilead stock rose just 0.2% to close at 65.42. In after-hours...Street's...